Recurrent Non-Squamous Non-Small Cell Lung Carcinoma
2 clinical trials · Condition
◉ Watch Recurrent Non-Squamous Non-Small Cell Lung Carcinoma
| Record | Firm | Date |
|---|---|---|
| Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT03845296) | SWOG Cancer Research Network | 2019-04-16 |
| Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations (NCT03299088) | Jonathan Riess | 2018-06-26 |
Track Recurrent Non-Squamous Non-Small Cell Lung Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.